Abstract
Purpose. The goal of this investigation was to demonstrate whether the intrinsic flux of a drug diffusing across a membrane mounted in a flow-through diffusion cell may be accurately and easily determined by accounting for the accumulation in the receiver chamber.
Methods. Mathematical modeling, applied to transdermal diffusion, was used to calculate receiver concentration data for single layer and bilayer membranes. The data were interpreted using two apparent flux values, Jappl and Japp2. Japp1 has been used extensively in the literature, but did not account for accumulation in the receiver. Japp2 did take the accumulation into consideration.
Results. The results confirm that, generally, Jappl values were not accurate estimates of the intrinsic flux. Japp2 values were significantly more accurate, especially prior to the maximum in receiver concentration.
Conclusions. Japp2 was an accurate measurement of intrinsic flux over the entire experimental time period, except at time zero. It was more accurate because it accounted for solute accumulation in the receiver compartment. The accuracy of the Japp2 approximation was practically independent of receiver volume, flow rate and donor volume. For very slowly permeating drugs, or a very small receiver volume combined with a high flow rate, the Japp1 estimate accurately reflected the intrinsic flux. Early time data were required to properly account for accumulation in the receiver cell. If such data were not available, the inverse Laplace method of determining intrinsic flux was preferable to the Japp2 calculation.
Similar content being viewed by others
REFERENCES
J. Sclafani, J. Nightingale, P. Liu, and T. Kurihara-Bergstrom. Flow-Through System Effects on in Vitro Analysis of Transdermal Systems. Pharm. Res. 10: 1521–1526 (1993).
E. R. Cooper. Increased Skin Permeability for Lipophilic Molecules. J. Pharm. Sci. 73: 1153–1156 (1984).
V. M. Knepp, R. S. Hinz, F. C. Szoka, and R. H. Guy. Controlled Drug Release From a Novel Liposomal Delivery System. I. Investigation of Transdermal Potential. J. Controlled Release. 5: 211–221 (1988).
T. Kai, V. H. W. Mak, R. O. Potts, and R. H. Guy. Mechanism of Percutaneous Penetration Enhancement: Effect of n-Alkanols on the Permeability Barriers of Hairless Mouse Skin. J. Controlled Release. 12: 103–112 (1990).
W. J. Addicks, G. L. Flynn, and N. Weiner. Validation of a Flow-Through Diffusion Cell for Use in Transdermal Research. Pharm. Res. 4: 337–341 (1987).
W. Addicks, N. Weiner, G. Flynn, R. Curl, and E. Topp. Topical Drug Delivery from Thin Applications: Theoretical Predictions and Experimental Results. Pharm. Res. 7: 1048–1054 (1990).
W. G. Reifenrath, B. Lee, D. R. Wilson, and T. S. Spencer. A Comparison of In Vitro Skin-Penetration Cells. J. Pharm. Sci. 83: 1229–1233 (1994).
R. L. Bronaugh and R. F. Stewart. Methods for In Vitro Percutaneous Absorption Studies IV: the Flow-Through Diffusion Cell. J. Pharm. Sci. 74: 64–67 (1985).
S. A. Akhter, S. L. Bennett, I. L. Waller, and B. W. Barry. An Automated Diffusion Apparatus for Studying Skin Penetration. Inter. J. Pharm. 21: 17–26 (1984).
M. Goodman and B. W. Barry. Lipid-Protein-Partitioning (LPP) Theory of Skin Enhancer Activity: Finite Dose Technique. Inter. J. Pharm. 57: 29–40 (1989).
A. C. Williams and B. W. Barry. Terpenes and the Lipid-Protein-Partitioning Theory of Skin Penetration Enhancement. Pharm. Res. 8: 17–24 (1991).
D. Friend, P. Catz, J. Heller, J. Reid, and R. Baker. Transdermal Delivery of Levonorgestrel I: Alkanols as Permeation Enhancers In Vitro. J. Controlled Release. 7: 243–250 (1988).
D. R. Friend, P. Catz, J. Heller, and M. Okagaki. Transdermal Delivery of Levonorgestrel. V. Preparation of Devices and Evaluation in Vitro. Pharm. Res. 6: 938–944 (1989).
P. Catz and D. R. Friend. Transdermal Delivery of Levonorgestrel. VIII. Effect of Enhancers on Rat Skin, Hairless Mouse Skin, Hairless Guinea Pig Skin, and Human Skin. Inter. J. Pharm. 58: 93–102 (1990).
M. Akazawa, T. Itoh, K. Masaki, B. T. Nghiem, N. Tsuzuki, R. Konishi, and T. Higuchi. An Automated Method for Continuously Monitoring Diffusion Cells in Skin Penetration Studies. Inter. J. Pharm. 50: 53–60 (1989).
K. Knutson, D. J. Harrison, L. K. Pershing, and C. Y. Goates. Transdermal Absorption of Steroids. J. Controlled Release. 24: 95–108 (1993).
H. Durrheim, G. L. Flynn, W. I. Higuchi, and C. R. Behl. Permeation of Hairless Mouse skin I: Experimental Methods and Comparison with Human Epidermal Permeation by Alkanols. J. Pharm. Sci. 69: 781–786 (1980).
P. Liu, T. Kurihara-Bergstrom, and W. R. Good. Cotransport of Estradiol and Ethanol Through Human Skin in Vitro: Understanding the Permeant/Enhancer Flux Relationship. Pharm. Res. 8: 938–944 (1991).
L. A. Kurtz, R. E. Smith, C. L. Parks, and L. R. Boney. A Comparison of the Method of Lines to Finite Difference Techniques in Solving Time-Dependent Partial Differential Equations. Computers and Fluids. 6: 49–70 (1978).
A. C. Hindmarsh. LSODE and LSODI, Two New Initial Value Ordinary Differential Equation Solvers. ACM-Signum Newsletter. 15: 10–11 (1980).
H.-K. Choi and J. T. Angello. Mathematical Analysis and Optimization of a Flow-Through Diffusion Cell System. Pharm. Res. 11: 595–599 (1994).
Rights and permissions
About this article
Cite this article
Harrison, D.J., Knutson, K. Accurate Determination of Skin Flux from Flow-Through Diffusion Cell Data. Pharm Res 12, 2003–2011 (1995). https://doi.org/10.1023/A:1016216611809
Issue Date:
DOI: https://doi.org/10.1023/A:1016216611809